Table 1.

Distribution of lymphoma histotypes in individuals infected by HIV over 30 years in a European cohort (615 patients) compared with the CNICS USA cohort (476 patients)

Histotype1986-1995; London (158 patients)1996-2005; London (200 patients)2006-2015; London (257 patients)1996-2000; CNICS (132 patients)2001-2005; CNICS (201 patients)2006-2010; CNICS (143 patients)
BL 3% 10% 20% ↑ 7.6% 10.9% 16.8% ↑ 
DLBCL 63% 59% 37% ↓ 43.9% 45.8% 35.7% ↓ 
HL 4% 11% 26% ↑ 15.2% 15.4% 19.6% ↑ 
PCNSL    14.4% 10.4% 9.8% ↓ 
PBL 2% 6% ↑    
PEL 2% 1% 5% ↑    
Other    18.9% 17.4% 18.2% 
Histotype1986-1995; London (158 patients)1996-2005; London (200 patients)2006-2015; London (257 patients)1996-2000; CNICS (132 patients)2001-2005; CNICS (201 patients)2006-2010; CNICS (143 patients)
BL 3% 10% 20% ↑ 7.6% 10.9% 16.8% ↑ 
DLBCL 63% 59% 37% ↓ 43.9% 45.8% 35.7% ↓ 
HL 4% 11% 26% ↑ 15.2% 15.4% 19.6% ↑ 
PCNSL    14.4% 10.4% 9.8% ↓ 
PBL 2% 6% ↑    
PEL 2% 1% 5% ↑    
Other    18.9% 17.4% 18.2% 

Since the introduction of cART, the incidence of NHL has decreased by 50% mainly because of decreased PCNSL and the immunoblastic histologic subtype of DLBCL, consistent with CD4 counts. In contrast, the burden of HIV-associated BL and HL has increased16: pre-cART decade (1986-1995); early cART decade (1996-2005); late cART decade (2006-2015). European cohort26; CNICS USA cohort.25 ↑, increase of proportion in late cART decade; ↓, decrease of proportion in late cART decade.

Close Modal

or Create an Account

Close Modal
Close Modal